Mariapia Degli-Esposti
Mariapia Degli-Esposti
Подтвержден адрес электронной почты в домене monash.edu
TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL
H Walczak, MA Degli-Esposti, RS Johnson, PJ Smolak, JY Waugh, ...
The EMBO journal 16 (17), 5386-5397, 1997
The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
MA Degli-Esposti, WC Dougall, PJ Smolak, JY Waugh, CA Smith, ...
Immunity 7 (6), 813-820, 1997
Activation of NK cell cytotoxicity
MJ Smyth, E Cretney, JM Kelly, JA Westwood, SEA Street, H Yagita, ...
Molecular immunology 42 (4), 501-510, 2005
Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
MA Degli-Esposti, PJ Smolak, H Walczak, J Waugh, CP Huang, ...
The Journal of experimental medicine 186 (7), 1165-1170, 1997
Close encounters of different kinds: dendritic cells and NK cells take centre stage
MA Degli-Esposti, MJ Smyth
Nature Reviews Immunology 5 (2), 112-124, 2005
Functional interactions between dendritic cells and NK cells during viral infection
DM Andrews, AA Scalzo, WM Yokoyama, MJ Smyth, MA Degli-Esposti
Nature immunology 4 (2), 175-181, 2003
ILC1 confer early host protection at initial sites of viral infection
OE Weizman, NM Adams, IS Schuster, C Krishna, Y Pritykin, C Lau, ...
Cell 171 (4), 795-808. e12, 2017
Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity
CE Andoniou, SLH van Dommelen, V Voigt, DM Andrews, G Brizard, ...
Nature immunology 6 (10), 1011-1019, 2005
NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation
ND Huntington, H Tabarias, K Fairfax, J Brady, Y Hayakawa, ...
the Journal of Immunology 178 (8), 4764-4770, 2007
Infection of dendritic cells by murine cytomegalovirus induces functional paralysis
DM Andrews, CE Andoniou, F Granucci, P Ricciardi-Castagnoli, ...
Nature immunology 2 (11), 1077-1084, 2001
CIS is a potent checkpoint in NK cell–mediated tumor immunity
RB Delconte, TB Kolesnik, LF Dagley, J Rautela, W Shi, EM Putz, ...
Nature immunology 17 (7), 816-824, 2016
Interleukin 15–mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
ND Huntington, H Puthalakath, P Gunn, E Naik, EM Michalak, MJ Smyth, ...
Nature immunology 8 (8), 856-863, 2007
Ancestral haplotypes: conserved population MHC haplotypes
MA Degli-Esposti, AL Leaver, FT Christiansen, CS Witt, LJ Abraham, ...
Human immunology 34 (4), 242-252, 1992
A contribution of mouse dendritic cell–derived IL-2 for NK cell activation
F Granucci, I Zanoni, N Pavelka, SLH Van Dommelen, CE Andoniou, ...
The Journal of experimental medicine 200 (3), 287-295, 2004
A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment
A Young, SF Ngiow, Y Gao, AM Patch, DS Barkauskas, M Messaoudene, ...
Cancer research 78 (4), 1003-1016, 2018
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
DM Andrews, MJ Estcourt, CE Andoniou, ME Wikstrom, A Khong, V Voigt, ...
Journal of Experimental Medicine 207 (6), 1333-1343, 2010
β‐glucan triggers spondylarthritis and Crohn's disease–like ileitis in SKG mice
M Ruutu, G Thomas, R Steck, MA Degli‐Esposti, MS Zinkernagel, ...
Arthritis & rheumatism 64 (7), 2211-2222, 2012
Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells
V Voigt, CA Forbes, JN Tonkin, MA Degli-Esposti, HRC Smith, ...
Proceedings of the National Academy of Sciences 100 (23), 13483-13488, 2003
CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation
LE Tze, K Horikawa, H Domaschenz, DR Howard, CM Roots, RJ Rigby, ...
Journal of Experimental Medicine 208 (1), 149-165, 2011
To die or not to die—the quest of the TRAIL receptors
M Degli-Esposti
Journal of leukocyte biology 65 (5), 535-542, 1999
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20